
NeuroKids - Child Neurology Workbook
Description
Alles über E-Books | Antworten auf Fragen rund um E-Books, Kopierschutz und Dateiformate finden Sie in unserem Info- & Hilfebereich.
More details
Other editions
Additional editions

Person
Content
- Cover
- Title
- Imprint
- Preface of the editor and co-editors
- Preface of the EPNS
- Introduction NeuroKids-App and -Workbook
- Credits
- Cooperations
- List of authors
- Content
- Abbreviations
- A Emergency and intensive care
- A. 01 Febrile seizures
- PCS-Diagnosis
- A. 01 Febrile seizures
- PCS-Therapy
- Emergency and intensive care
- A. 02 Status epilepticus ( SE)
- A. 03 Acute dystonic reaction A.03 Acute dystonic reaction
- PCS-Diagnosis
- A. 03 Acute dystonic reaction A.03 Acute dystonic reaction
- PCS-Therapy
- A. 04 Acute Ataxia A.04 Acute Ataxia
- PCS-Diagnosis
- A. 04 Acute Ataxia A.04 Acute Ataxia
- PCS-Diagnosis
- A. 05 Acute increased intracranial pressure ( ICP)
- PCS-Diagnosis
- A. 05 Acute increased intracranial pressure ( ICP)
- PCS-Therapy
- A. 05 Acute increased intracranial pressure ( ICP)
- PCS-Therapy
- A. 06 Guillain- Barré Syndrome ( GBS)
- PCS-Diagnosis
- A. 06 Guillain- Barré syndrome ( GBS)
- PCS-Therapy, part 1
- A. 06 Guillain- Barré syndrome ( GBS)
- PCS-Therapy, part 2
- A. 07 Neurometabolic dysfunction
- PCS-Classification
- A. 07 Neurometabolic dysfunction
- PCS-Acute intervention
- A. 07 Neurometabolic dysfunction
- PCS-Therapy following: confirmation of suspected diagnosis
- A. 07 Neurometabolic dysfunction
- PCS-Specific therapy: Type I
- A. 07 Neurometabolic dysfunction
- PCS-Specific therapy: Type II/III
- A. 08 Traumatic brain injury ( TBI)
- PCS-Diagnosis
- A. 08 Traumatic brain injury ( TBI)
- PCS-Therapy
- A. 09 Paediatric stroke
- PCS-Diagnosis, part 1
- A. 09 Paediatric stroke
- PCS-Diagnosis, part 2
- A. 09 Paediatric stroke
- PCS-Acute therapy
- A. 09.1 Thromboembolic events
- PCS-Diagnosis, part 1
- A. 09.1 Thromboembolic events
- PCS-Diagnosis, part 2
- A. 09.1 Thromboembolic events
- PCS-Therapy, part 1
- A. 09.1 Thromboembolic events
- PCS-Therapy, part 2
- A. 09.1 Thromboembolic events
- PCS-Secondary prophylaxis
- A. 09.2 Intracranial haemorrhage/ bleeding
- PCS-Diagnosis
- A. 09.2 Intracranial haemorrhage/ bleeding
- PCS-Diagnosis
- A. 09.2 Intracranial haemorrhage/ bleeding
- PCS-Therapy
- A. 09.2 Intracranial haemorrhage/ bleeding
- PCS-Diagnosis (Trauma)
- A. 09.2 Intracranial haemorrhage/ bleeding
- PCS-Diagnosis (Trauma)
- A. 09.2 Intracranial haemorrhage/ bleeding
- PCS-Diagnosis (Trauma)
- A. 09.2 Intracranial haemorrhage/ bleeding
- PCS-Therapy (Trauma)
- A. 09.3 Cerebral venous sinus thrombosis
- PCS-General approach to diagnosis, part 1
- A. 09.3 Cerebral venous sinus thrombosis
- PCS-General approach to diagnosis, part 2
- A. 09.3 Cerebral venous sinus thrombosis
- PCS-Therapy
- A. 09.4 Dissection ( cerebrovascular)
- PCS-Diagnosis
- A. 09.4 Dissection ( cerebrovascular)
- PCS-Diagnosis
- A. 09.4 Dissection ( cerebrovascular)
- PCS-Therapy
- A. 09.5 Arteriovenous malformations
- PCS-Diagnosis cerebral, part 1
- A. 09.5 Arteriovenous malformations
- PCS-Diagnosis cerebral, part 2
- A. 09.5 Arteriovenous malformations
- PCS-Diagnosis cerebral, part 2
- A. 09.5 Arteriovenous malformations
- PCS-Therapy cerebral
- A. 09.5 Arteriovenous malformations
- PCS-Diagnosis spinal
- A. 09.5 Arteriovenous malformations
- PCS-Diagnosis spinal
- A. 09.5 Arteriovenous malformations
- PCS-Therapy spinal
- A. 10 Battered child
- PCS-How to proceed in case of suspected child abuse
- A. 11 Coma
- PCS-Diagnosis overview
- A. 11 Coma
- PCS-Diagnosis Coma plus altered vital signs
- A. 11 Coma
- PCS-Diagnosis Coma plus focal neurological signs
- A. 11 Coma
- PCS-Diagnosis Coma plus specific history/clinical signs
- A. 11 Coma
- PCS-Diagnosis Coma plus specific history/clinical signs
- A. 11 Coma
- PCS-Diagnosis Coma plus specific history/clinical signs
- A. 11 Coma
- PCS-Diagnosis Coma without relevant medical history
- A. 11 Coma
- PCS-Diagnosis Coma secondary deterioration
- A. 11 Coma
- PCS-Treatment
- A. 11 Coma
- PCS-Treatment
- A. 12 Brain death
- PCS-Diagnosis Brain death
- A. 13 Intoxications
- PCS-Leading symptoms
- A. 13 Intoxications
- PCS-General measures
- A. 13 Intoxications
- PCS-General measures
- Notes
- B Neonatology
- B. 01 Neonatal seizures
- PCS-Diagnosis
- B. 01 Neonatal seizures
- PCS-Therapy
- B. 02 Neonatal hypoxic- ischaemic encephalopathy ( HIE)
- PCS-Diagnosis
- B. 02 Neonatal hypoxic- ischaemic encephalopathy ( HIE)
- PCS-Therapy
- Notes
- C Pain
- C. 01 Headache C.01 Headache
- PCS-Orientation
- C. 02 Primary Headache
- PCS-Diagnosis Tension-Type Headache vs. Migraine
- C. 02 Primary Headache
- PCS-Therapy Tension-Type Headache
- C. 02 Primary headache
- PCS-Therapy Migraine
- C. 03 Secondary Headache
- PCS-Overview
- C. 04 Pain management in palliative care
- PCS-Diagnosis
- C. 04 Pain management in palliative care
- PCS-Diagnosis
- C. 04 Pain management in palliative care
- PCS-Therapy
- C. 04 Pain management in palliative care
- PCS-Therapy in acute pain crisis
- C. 05 Idiopathic intracranial hypertension ( IIH)
- PCS-Diagnosis
- C. 05 Idiopathic intracranial hypertension ( IIH)
- PCS-Therapy
- D Development
- D. 01 Developmental disorders
- PCS-Orientation, part 1
- D. 01 Developmental disorders
- PCS-Orientation, part 2
- D. 02 Hyperkinetic disorder
- PCS-Diagnosis
- D. 02 Hyperkinetic disorder
- PCS-Therapy
- D. 03 Education entrance qualification ( school maturity)
- PCS-Diagnosis
- D. 04 Tic disorder and Tourette syndrome
- PCS-Diagnosis
- D. 04 Tic disorder and Tourette Syndrome
- PCS-Therapy
- D. 05 Autism spectrum disorder ( ASD)
- PCS-Diagnosis
- D. 06 Fetal alcohol spectrum disorders ( FASD)
- Notes
- E Epilepsy
- E. 01 Epilepsy
- PCS-Orientation
- E. 02 First seizure
- PCS-Diagnostic work-up
- E. 03 Paroxysomal events ( non- epileptic)
- PCS-Orientation
- E. 04 West- Syndrome
- PCS-Diagnostic work-up
- E. 05 Benign epilepsy with centrotemporal spikes ( BECTS, Rolandic epilepsy)
- PCS-Diagnostic work-up
- E. 06 Absence epilepsy
- PCS-Diagnostic work-up
- E. 07 Juvenile myoclonic epilepsy
- PCS-Diagnosis
- E. 07 Juvenile myoclonic epilepsy
- PCS-Therapy
- E. 08 Localizing signs in epilepsy
- PCS-Orientation
- E. 09 Therapeutic strategies in different electroclinical epilepsy syndromes
- PCS-Therapy
- E. 10 Epilepsy surgery
- PCS-Diagnosis/Therapy
- Notes
- F Vertigo
- F. 01 Vertigo and dizziness
- PCS-Diagnosis
- F. 01 Vertigo and dizziness
- PCS-Therapy
- Notes
- G Movement disorders
- G. 01 Cerebral palsy
- PCS-Diagnosis
- G. 01 Cerebral palsy
- PCS-Therapy
- G. 02 Dystonia
- PCS-Diagnosis
- G. 02 Dystonia
- PCS-Therapy
- Notes
- H Cranial nerves
- H. 01 Facial palsy
- PCS-Diagnosis
- H. 01 Facial palsy
- PCS-Therapy
- H. 02 Optic neuritis
- PCS-Diagnosis
- H. 02 Optic neuritis
- PCS-Therapy
- Notes
- I Rehabilitation
- I. 01 Rehabilitation ( inpatient)
- PCS-Diagnosis/Therapy
- Notes
- J Inflammation and infection
- J. 01 Multiple sclerosis/ ADEM
- PCS-Diagnosis
- J. 01 Multiple sclerosis/ ADEM
- PCS-McDonald Criteria
- J. 01 Multiple sclerosis/ ADEM
- PCS-Acute therapy
- J. 01 Multiple sclerosis/ ADEM
- PCS-Disease modifying drugs (DMD)
- J. 02 Cerebral vasculitis
- PCS-Diagnosis
- J. 02 Cerebral vasculitis
- PCS-Therapy
- J. 03 Lyme disease
- PCS-Diagnosis
- J. 03 Lyme disease
- PCS-Therapy
- J. 04 Meningitis and encephalitis
- PCS-Diagnosis
- J. 04 Meningitis and encephalitis
- PCS-Therapy
- Notes
- K Oncology
- K. 01 Neoplasm of the CNS
- PCS-Diagnosis Brain
- K. 01 Neoplasm of the CNS
- PCS-Diagnosis Spine
- K. 01 Neoplasm of the CNS
- WHO classification of tumors
- Notes
- L Genetics
- L. 01 Genetics
- PCS-Orientation
- L. 02 Neurocutaneous syndromes
- PCS-Diagnosis Neurofibromatosis 1 (NF1)
- L. 02 Neurocutaneous syndromes
- PCS-Therapy Neurofibromatosis 1 (NF1)
- L. 02 Neurocutaneous syndromes
- PCS-Diagnosis Neurofibromatosis 2 (NF2)
- L. 02 Neurocutaneous syndromes
- PCS-Therapy Neurofibromatosis 2 (NF2)
- L. 02 Neurocutaneous syndromes
- PCS-Diagnosis Tuberous sclerosis complex (TSC)
- L. 02 Neurocutaneous syndromes
- PCS-Therapy Tuberous sclerosis complex (TSC)
- L. 03 Craniosynostosis
- PCS-Diagnosis
- L. 03 Craniosynostosis
- PCS-Therapy
- L. 04 Rett syndrome
- PCS-Diagnosis
- L. 04 Rett syndrome
- PCS-Therapy
- L. 05 Microdeletion syndromes
- PCS-Diagnosis Angelman syndrome
- L. 05 Microdeletion syndromes
- PCS-Therapy Angelman syndrome
- L. 05 Microdeletion syndromes
- PCS-Diagnosis Prader-Willi syndrome
- L. 05 Microdeletion syndromes
- PCS-Therapy Prader-Willi syndrome
- L. 06 Trisomy 21
- PCS-Overview 1
- L. 06 Trisomy 21
- PCS-Overview 2
- Notes
- M Autonomic nerve system
- M. 01 Hypersalivation and dysphagia
- PCS-Diagnosis
- M. 01 Hypersalivation and dysphagia
- PCS-Therapy
- M. 02 Bladder dysfunction
- PCS-Diagnosis
- M. 03 Sleep disorders
- PCS-Diagnosis
- M. 03 Sleep disorders
- PCS-Therapy
- Notes
- N Neurometabolic and neurodegenerative disorders
- N. 01 Neurometabolic disorders
- PCS-Diagnostic approach
- N. 01 Neurometabolic disorders
- PCS-Symptoms, specific laboratory tests
- N. 01 Neurometabolic disorders
- PCS-Cerebrospinal fluid (CSF) diagnostic work-up
- N. 01 Neurometabolic disorders
- PCS-Specific therapies
- N. 02 Neurodegenerative disorders
- PCS-Orientation
- N. 02 Neurodegenerative disorders
- PCS-Differential diagnosis of psychomotor regression - non-neurometabolic
- N. 03 Mitochondrial disorders
- PCS-Diagnosis
- N. 03 Mitochondrial disorders
- PCS-Therapy
- Notes
- O Neuromuscular disorders
- O. 01 Neuromuscular disorders
- PCS-Orientation
- O. 02 Muscle dystrophies
- O. 02.1 Duchenne- Becker muscular dystrophy ( DMD, BMD)
- PCS-Diagnosis
- O. 02.1 Duchenne- Becker muscular dystrophy ( DMD, BMD)
- PCS-Therapy
- O. 02.2 Limb- girdle muscular dystrophy ( LGMD)
- PCS-Diagnosis
- O. 02.2 Limb- girdle muscular dystrophy ( LGMD)
- PCS-Therapy
- O. 02.3 Emery- Dreifuss Syndrome
- PCS-Diagnosis
- O. 02.3 Emery- Dreifuss Syndrome
- PCS-Therapy
- O. 02.4 Myotonic dystrophy, Dystrophia myotonica ( DM)
- PCS-Diagnosis
- O. 02.4 Myotonic dystrophy, Dystrophia myotonica ( DM)
- PCS-Therapy
- O. 02.5 Facio- scapulo- humeral muscular dystrophy ( FSHD)
- PCS-Diagnosis
- O. 02.5 Facio- scapulo- humeral muscular dystrophy ( FSHD)
- PCS-Therapy
- O. 02.6 Distal muscular dystrophy
- PCS-Diagnosis
- O. 02.6 Distal muscular dystrophy
- PCS-Therapy
- O. 02.7 Congenital muscular dystrophy ( CMD)
- PCS-Diagnosis
- O. 02.7 Congenital muscular dystrophy ( CMD)
- PCS-Therapy
- O. 03 Myopathies
- PCS-Diagnosis congenital myopathy
- O. 03 Myopathies
- PCS-Therapy congenital myopathy
- O. 03 Myopathies
- PCS-Diagnosis metabolic myopathy
- O. 03 Myopathies
- PCS-Therapy metabolic myopathy
- O. 04 Myositis
- PCS-Diagnosis
- O. 04 Myositis
- PCS-Therapy
- O. 05 Spinal muscular atrophy ( SMA)
- PCS-Diagnosis
- O. 05 Spinal muscular atrophy ( SMA)
- PCS-Therapy
- O. 06 Neuromuscular transmission
- PCS-Diagnosis
- O. 06 Neuromuscular transmission
- PCS-Therapy
- O. 07 Peripheral nerve lesions
- PCS-Overview Obstetric brachial palsy
- O. 07 Peripheral nerve lesions
- PCS-Therapy Obstetric brachial palsy
- O. 08 Neuropathies
- PCS-Diagnosis
- Notes
- P Hydrocephalus, Myelomeningocele (MMC), Chiari Malformations
- P. 01 Hydrocephalus in infants
- PCS-Diagnosis
- P. 01 Hydrocephalus in infants
- PCS-Therapy
- P. 02 Management of the shunted hydrocephalus
- P. 03 Myelomeningocele ( MMC)
- PCS-Diagnosis
- P. 03 Myelomeningocele ( MMC)
- PCS-Therapy
- P. 04 Chiari malformations ( CM)
- PCS-Diagnosis
- P. 04 Chiari malformations ( CM)
- PCS-Therapy
- Notes
- Q Neuro-Orthopaedics
- Q. 01 Hip joint
- PCS-Diagnosis
- Q. 01 Hip joint
- PCS-Therapy
- Q. 02 Scoliosis
- PCS-Diagnosis
- Q. 02 Scoliosis
- PCS-Therapy
- Notes
- R Neurological examinations
- R. 01 Neurological examinations ( from 2 years of age)
- R. 02 6 minutes neurological examination
- R. 03 Developmental assessment - overview & orientation
- R. 04.1 Basic developmental assessment - up to 20 days Neurological examinations
- R. 04.2 Basic developmental assessment - 4th to end of 8th week Neurological examinations
- R. 04.3 Basic developmental assessment - 3rd to end of 4th months Neurological examinations
- R. 04.4 Basic developmental assessment - 6th to end of 8th months Neurological examinations
- R. 04.5 Basic developmental assessment - 11th to end of 13th months Neurological examinations
- R. 04.6 Basic developmental assessment - 17th to end of 19th months
- ?
- R. 04.7 Basic developmental assessment - 21st to end of 26th months Neurological examinations
- Notes
- Medication
- A
- Acetazolamide (AZA)
- Acetylsalicylic acid (ASA)
- Aciclovir
- ACTH
- Activated charcoal
- Almotriptan
- Amantadine
- 4-Aminopyridine
- Amitriptyline
- Amphotericin B
- Ampicillin
- Atomoxetine
- Atropine
- Azathioprine
- B
- Baclofen
- Benzatropine
- Benzhexol
- Benzylpenicillin
- Biperiden
- Botulinum toxins
- Bromides
- Bromocriptine
- Butylscopolamine
- C
- Caffeine
- Calcium and Vitamin D
- Carbamazepine (CBZ)
- Carglumic acid
- L-Carnitine
- Cefotaxime
- Ceftriaxone
- Chloral hydrate
- Ciclosporin A
- Clobazam (CLB)
- Clomethiazole
- Clonazepam
- Clonidine
- Clopidogrel
- Coenzyme Q10
- Creatine monohydrate
- Cyclophosphamide
- D
- Danaparoid sodium
- Dantrolene
- Dapsone
- Desmopressin
- Dexamethasone
- 3,4-Diaminopyridine
- Diazepam (DZP)
- Diazoxide
- Diclofenac
- Dimenhydrinate
- Dipyridamole
- Doxepin
- Doxycycline
- E
- Edrophonium chloride
- Ephedrine
- Eslicarbazepine
- Etanercept
- Ethosuximide (ESM)
- F
- Felbamate (FBM)
- Fentanyl
- Fluconazole
- Flucytosine
- Flunarizine
- Fluoxetine
- Flupirtine
- Folinic acid
- Foscarnet
- Furosemide
- G
- Gabapentin (GBP)
- Ganciclovir
- Gentamicin
- Glatiramer acetate
- Glucagon
- Glycopyrronium bromide
- H
- Haloperidol
- Heparin
- Hydroxocobalamin
- I
- Ibuprofen
- Idebenone
- Imipenem
- Infliximab
- Interactions of anticonvulsive drugs
- Interferon beta-1a
- Interferon beta-1b
- Intravenous immunoglobulins (IVIG)
- Itraconazole
- K
- Ketamine
- L
- Lacosamide
- Lamotrigine (LTG)
- Lepirudin
- Levetiracetam (LEV)
- Levodopa
- Lidocaine
- Lorazepam (LZP)
- M
- Magnesium
- Mannitol
- Melatonin
- Metamizole
- Methotrexate (MTX)
- Methsuximide
- Methylphenidate
- Methylprednisolone
- Metoprolol
- Mexiletine
- Midazolam (MDL)
- Mirtazapine
- Mitoxantrone
- Morphine
- Mycophenolate mofetil
- N
- Natalizumab
- Neostigmine
- Nitrazepam (NZP)
- O
- Orphenadrine
- Oxcarbazepine (OXC)
- Oxybutynin
- P
- Pamidronate
- Paracetamol (or Acetaminophen)
- Peppermint oil
- Petasites extract
- Pethidine (or Meperidine)
- Phenobarbital (PhB)
- Phenprocoumon
- Phenytoin (DPH)
- Pimozide
- Piracetam
- Pleconaril
- Prednisolone
- Prednisone
- Pregabalin (PGB)
- Primidone (PRM)
- Procyclidine
- Promethazine
- Propiverine
- Propofol
- Propranolol
- Pyridostigmine
- Pyridoxal phosphate (PALP, PLP, P5P)
- Pyridoxine
- R
- Risperidone
- Rituximab
- Rizatriptan
- Rufinamide
- S
- Scopolamine
- Stiripentol
- Sulthiame (STM)
- Sumatriptan
- T
- Tacrolimus
- Tetrabenazine
- Tetrazepam
- Theophylline
- Thiopental
- Tiagabine
- Tiapride
- Tizanidine
- Tolperisone
- Topiramate (TPM)
- Trazodone
- Trihexyphenidyl
- V
- Valproic acid
- Vigabatrin
- Voriconazole
- W
- Warfarin
- Z
- Zolmitriptan
- Zonisamide
- Notes
System requirements
File format: PDF
Copy protection: Watermark-DRM (Digital Rights Management)
System requirements:
- Computer (Windows; MacOS X; Linux): Use the free software Adobe Reader, Adobe Digital Editions, or any other PDF viewer of your choice (see eBook Help).
- Tablet/Smartphone (Android; iOS): Install the free app Adobe Digital Editions or another reading app for eBooks, e.g., PocketBook (see eBook Help).
- E-reader: Bookeen, Kobo, Pocketbook, Sony, Tolino and many more (only limited: Kindle).
The file format PDF always displays a book page identically on any hardware. This makes PDF suitable for complex layouts such as those used in textbooks and reference books (images, tables, columns, footnotes). Unfortunately, on the small screens of e-readers or smartphones, PDFs are rather annoying, requiring too much scrolling.
This eBook uses Watermark-DRM, a „soft” copy protection. This means that there are no technical restrictions to prevent illegal distribution. However, there is a personalised watermark embedded in the eBook that can be used to identify the purchaser of the eBook in the event of misuse and to provide evidence for legal purposes.
For more information, see our eBook Help page.